Since the ferromagnetic (Fe 3 O 4) nanoparticles were firstly reported to exert enzyme-like
activity in 2007, extensive research progress in nanozymes has been made with deep …

Inflammatory bowel diseases (IBDs) are chronic problems of gastrointestinal tract (GIT) with
poorly understood aetiology. Patients with any of the two common entities, Crohn's disease …

Inflammatory bowel disease can be caused by the dysfunction of the intestinal mucosal
barrier and dysregulation of gut microbiota. Traditional treatments use drugs to manage …

While conventional approaches for inflammatory bowel diseases mainly focus on
suppressing hyperactive immune responses, it remains unclear how to address disrupted …

Safe, effective, and convenient administration of therapeutic nanomaterials is one of the
greatest difficulties in nanomedicine. To tackle this challenge, a system which couples multi …

The excessive reactive oxygen species (ROS) is a hallmark associated with the initiation
and progression of inflammatory bowel disease (IBD), which execrably form a vicious cycle …

The histologic examination of endoscopic biopsies or resection specimens remains a key
step in the work-up of affected inflammatory bowel disease (IBD) patients and can be used …

Inflammatory bowel disease (IBD) is a chronic gastrointestinal tract disorder characterized
by uncontrolled inflammatory responses to the disrupted intestinal epithelial barrier and gut …

Histomorphology remains a powerful routine evaluating intestinal inflammation in animal
models. Emphasizing the focus of a given animal study, histopathology can overstate …

This review provides a summary of the global epidemiology of inflammatory bowel diseases
(IBD). It is now clear that IBD is increasing worldwide and has become a global emergence …